The global Lipid Microbubble Contrast Agent market was valued at US$ 565 million in 2023 and is anticipated to reach US$ 797.4 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.

Lipid Microbubble Contrast Agent Market

Lipid microbubble contrast agent is a drug or substance commonly used in medical imaging to image blood vessels or tissues. This contrast agent is composed primarily of lipids (usually phospholipids) and is often coated with a gas or other contrast agent.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Lipid Microbubble Contrast Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lipid Microbubble Contrast Agent.

Report Scope

The Lipid Microbubble Contrast Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lipid Microbubble Contrast Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lipid Microbubble Contrast Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Lipid Microbubble Contrast Agent Market Report

Report Metric	Details
Report Name	Lipid Microbubble Contrast Agent Market
Accounted market size in 2023	US$ 565 million
Forecasted market size in 2030	US$ 797.4 million
CAGR	5.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Micron Nanoscale
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Lantheus Medical Imaging, Bracco SpA, GE Healthcare, Daiichi Sankyo Company, Bayer, Guerbet Group, Hengrui Medicine, BeiLu Pharmaceutical, Qihui Biology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lipid Microbubble Contrast Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lipid Microbubble Contrast Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Lipid Microbubble Contrast Agent Market growing?

Ans: The Lipid Microbubble Contrast Agent Market witnessing a CAGR of 5.0% during the forecast period 2024-2030.

What is the Lipid Microbubble Contrast Agent Market size in 2030?

Ans: The Lipid Microbubble Contrast Agent Market size in 2030 will be US$ 797.4 million.

Who are the main players in the Lipid Microbubble Contrast Agent Market report?

Ans: The main players in the Lipid Microbubble Contrast Agent Market are Lantheus Medical Imaging, Bracco SpA, GE Healthcare, Daiichi Sankyo Company, Bayer, Guerbet Group, Hengrui Medicine, BeiLu Pharmaceutical, Qihui Biology

What are the Application segmentation covered in the Lipid Microbubble Contrast Agent Market report?

Ans: The Applications covered in the Lipid Microbubble Contrast Agent Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Lipid Microbubble Contrast Agent Market report?

Ans: The Types covered in the Lipid Microbubble Contrast Agent Market report are Micron, Nanoscale

1 Lipid Microbubble Contrast Agent Market Overview

1.1 Product Overview and Scope of Lipid Microbubble Contrast Agent

1.2 Lipid Microbubble Contrast Agent Segment by Type

1.2.1 Global Lipid Microbubble Contrast Agent Market Value Comparison by Type (2024-2030)

1.2.2 Micron

1.2.3 Nanoscale

1.3 Lipid Microbubble Contrast Agent Segment by Application

1.3.1 Global Lipid Microbubble Contrast Agent Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Lipid Microbubble Contrast Agent Market Size Estimates and Forecasts

1.4.1 Global Lipid Microbubble Contrast Agent Revenue 2019-2030

1.4.2 Global Lipid Microbubble Contrast Agent Sales 2019-2030

1.4.3 Global Lipid Microbubble Contrast Agent Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Lipid Microbubble Contrast Agent Market Competition by Manufacturers

2.1 Global Lipid Microbubble Contrast Agent Sales Market Share by Manufacturers (2019-2024)

2.2 Global Lipid Microbubble Contrast Agent Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Lipid Microbubble Contrast Agent Average Price by Manufacturers (2019-2024)

2.4 Global Lipid Microbubble Contrast Agent Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Lipid Microbubble Contrast Agent, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Lipid Microbubble Contrast Agent, Product Type & Application

2.7 Lipid Microbubble Contrast Agent Market Competitive Situation and Trends

2.7.1 Lipid Microbubble Contrast Agent Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Lipid Microbubble Contrast Agent Players Market Share by Revenue

2.7.3 Global Lipid Microbubble Contrast Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Lipid Microbubble Contrast Agent Retrospective Market Scenario by Region

3.1 Global Lipid Microbubble Contrast Agent Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Lipid Microbubble Contrast Agent Global Lipid Microbubble Contrast Agent Sales by Region: 2019-2030

3.2.1 Global Lipid Microbubble Contrast Agent Sales by Region: 2019-2024

3.2.2 Global Lipid Microbubble Contrast Agent Sales by Region: 2025-2030

3.3 Global Lipid Microbubble Contrast Agent Global Lipid Microbubble Contrast Agent Revenue by Region: 2019-2030

3.3.1 Global Lipid Microbubble Contrast Agent Revenue by Region: 2019-2024

3.3.2 Global Lipid Microbubble Contrast Agent Revenue by Region: 2025-2030

3.4 North America Lipid Microbubble Contrast Agent Market Facts & Figures by Country

3.4.1 North America Lipid Microbubble Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Lipid Microbubble Contrast Agent Sales by Country (2019-2030)

3.4.3 North America Lipid Microbubble Contrast Agent Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Lipid Microbubble Contrast Agent Market Facts & Figures by Country

3.5.1 Europe Lipid Microbubble Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Lipid Microbubble Contrast Agent Sales by Country (2019-2030)

3.5.3 Europe Lipid Microbubble Contrast Agent Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Lipid Microbubble Contrast Agent Market Facts & Figures by Country

3.6.1 Asia Pacific Lipid Microbubble Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Lipid Microbubble Contrast Agent Sales by Country (2019-2030)

3.6.3 Asia Pacific Lipid Microbubble Contrast Agent Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Lipid Microbubble Contrast Agent Market Facts & Figures by Country

3.7.1 Latin America Lipid Microbubble Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Lipid Microbubble Contrast Agent Sales by Country (2019-2030)

3.7.3 Latin America Lipid Microbubble Contrast Agent Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Lipid Microbubble Contrast Agent Market Facts & Figures by Country

3.8.1 Middle East and Africa Lipid Microbubble Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Lipid Microbubble Contrast Agent Sales by Country (2019-2030)

3.8.3 Middle East and Africa Lipid Microbubble Contrast Agent Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Lipid Microbubble Contrast Agent Sales by Type (2019-2030)

4.1.1 Global Lipid Microbubble Contrast Agent Sales by Type (2019-2024)

4.1.2 Global Lipid Microbubble Contrast Agent Sales by Type (2025-2030)

4.1.3 Global Lipid Microbubble Contrast Agent Sales Market Share by Type (2019-2030)

4.2 Global Lipid Microbubble Contrast Agent Revenue by Type (2019-2030)

4.2.1 Global Lipid Microbubble Contrast Agent Revenue by Type (2019-2024)

4.2.2 Global Lipid Microbubble Contrast Agent Revenue by Type (2025-2030)

4.2.3 Global Lipid Microbubble Contrast Agent Revenue Market Share by Type (2019-2030)

4.3 Global Lipid Microbubble Contrast Agent Price by Type (2019-2030)

5 Segment by Application

5.1 Global Lipid Microbubble Contrast Agent Sales by Application (2019-2030)

5.1.1 Global Lipid Microbubble Contrast Agent Sales by Application (2019-2024)

5.1.2 Global Lipid Microbubble Contrast Agent Sales by Application (2025-2030)

5.1.3 Global Lipid Microbubble Contrast Agent Sales Market Share by Application (2019-2030)

5.2 Global Lipid Microbubble Contrast Agent Revenue by Application (2019-2030)

5.2.1 Global Lipid Microbubble Contrast Agent Revenue by Application (2019-2024)

5.2.2 Global Lipid Microbubble Contrast Agent Revenue by Application (2025-2030)

5.2.3 Global Lipid Microbubble Contrast Agent Revenue Market Share by Application (2019-2030)

5.3 Global Lipid Microbubble Contrast Agent Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Lantheus Medical Imaging

6.1.1 Lantheus Medical Imaging Corporation Information

6.1.2 Lantheus Medical Imaging Description and Business Overview

6.1.3 Lantheus Medical Imaging Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Lantheus Medical Imaging Lipid Microbubble Contrast Agent Product Portfolio

6.1.5 Lantheus Medical Imaging Recent Developments/Updates

6.2 Bracco SpA

6.2.1 Bracco SpA Corporation Information

6.2.2 Bracco SpA Description and Business Overview

6.2.3 Bracco SpA Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Bracco SpA Lipid Microbubble Contrast Agent Product Portfolio

6.2.5 Bracco SpA Recent Developments/Updates

6.3 GE Healthcare

6.3.1 GE Healthcare Corporation Information

6.3.2 GE Healthcare Description and Business Overview

6.3.3 GE Healthcare Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2019-2024)

6.3.4 GE Healthcare Lipid Microbubble Contrast Agent Product Portfolio

6.3.5 GE Healthcare Recent Developments/Updates

6.4 Daiichi Sankyo Company

6.4.1 Daiichi Sankyo Company Corporation Information

6.4.2 Daiichi Sankyo Company Description and Business Overview

6.4.3 Daiichi Sankyo Company Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Daiichi Sankyo Company Lipid Microbubble Contrast Agent Product Portfolio

6.4.5 Daiichi Sankyo Company Recent Developments/Updates

6.5 Bayer

6.5.1 Bayer Corporation Information

6.5.2 Bayer Description and Business Overview

6.5.3 Bayer Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Bayer Lipid Microbubble Contrast Agent Product Portfolio

6.5.5 Bayer Recent Developments/Updates

6.6 Guerbet Group

6.6.1 Guerbet Group Corporation Information

6.6.2 Guerbet Group Description and Business Overview

6.6.3 Guerbet Group Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Guerbet Group Lipid Microbubble Contrast Agent Product Portfolio

6.6.5 Guerbet Group Recent Developments/Updates

6.7 Hengrui Medicine

6.6.1 Hengrui Medicine Corporation Information

6.6.2 Hengrui Medicine Description and Business Overview

6.6.3 Hengrui Medicine Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Hengrui Medicine Lipid Microbubble Contrast Agent Product Portfolio

6.7.5 Hengrui Medicine Recent Developments/Updates

6.8 BeiLu Pharmaceutical

6.8.1 BeiLu Pharmaceutical Corporation Information

6.8.2 BeiLu Pharmaceutical Description and Business Overview

6.8.3 BeiLu Pharmaceutical Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2019-2024)

6.8.4 BeiLu Pharmaceutical Lipid Microbubble Contrast Agent Product Portfolio

6.8.5 BeiLu Pharmaceutical Recent Developments/Updates

6.9 Qihui Biology

6.9.1 Qihui Biology Corporation Information

6.9.2 Qihui Biology Description and Business Overview

6.9.3 Qihui Biology Lipid Microbubble Contrast Agent Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Qihui Biology Lipid Microbubble Contrast Agent Product Portfolio

6.9.5 Qihui Biology Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Lipid Microbubble Contrast Agent Industry Chain Analysis

7.2 Lipid Microbubble Contrast Agent Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Lipid Microbubble Contrast Agent Production Mode & Process

7.4 Lipid Microbubble Contrast Agent Sales and Marketing

7.4.1 Lipid Microbubble Contrast Agent Sales Channels

7.4.2 Lipid Microbubble Contrast Agent Distributors

7.5 Lipid Microbubble Contrast Agent Customers

8 Lipid Microbubble Contrast Agent Market Dynamics

8.1 Lipid Microbubble Contrast Agent Industry Trends

8.2 Lipid Microbubble Contrast Agent Market Drivers

8.3 Lipid Microbubble Contrast Agent Market Challenges

8.4 Lipid Microbubble Contrast Agent Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Lantheus Medical Imaging

Bracco SpA

GE Healthcare

Daiichi Sankyo Company

List of Tables

Table 1. Global Lipid Microbubble Contrast Agent Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Lipid Microbubble Contrast Agent Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Lipid Microbubble Contrast Agent Market Competitive Situation by Manufacturers in 2023

Table 4. Global Lipid Microbubble Contrast Agent Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Lipid Microbubble Contrast Agent Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Lipid Microbubble Contrast Agent Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Lipid Microbubble Contrast Agent Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Lipid Microbubble Contrast Agent Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Lipid Microbubble Contrast Agent, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Lipid Microbubble Contrast Agent, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Lipid Microbubble Contrast Agent, Product Type & Application

Table 12. Global Key Manufacturers of Lipid Microbubble Contrast Agent, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Lipid Microbubble Contrast Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lipid Microbubble Contrast Agent as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Lipid Microbubble Contrast Agent Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Lipid Microbubble Contrast Agent Sales by Region (2019-2024) & (K Units)

Table 18. Global Lipid Microbubble Contrast Agent Sales Market Share by Region (2019-2024)

Table 19. Global Lipid Microbubble Contrast Agent Sales by Region (2025-2030) & (K Units)

Table 20. Global Lipid Microbubble Contrast Agent Sales Market Share by Region (2025-2030)

Table 21. Global Lipid Microbubble Contrast Agent Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Lipid Microbubble Contrast Agent Revenue Market Share by Region (2019-2024)

Table 23. Global Lipid Microbubble Contrast Agent Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Lipid Microbubble Contrast Agent Revenue Market Share by Region (2025-2030)

Table 25. North America Lipid Microbubble Contrast Agent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Lipid Microbubble Contrast Agent Sales by Country (2019-2024) & (K Units)

Table 27. North America Lipid Microbubble Contrast Agent Sales by Country (2025-2030) & (K Units)

Table 28. North America Lipid Microbubble Contrast Agent Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Lipid Microbubble Contrast Agent Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Lipid Microbubble Contrast Agent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Lipid Microbubble Contrast Agent Sales by Country (2019-2024) & (K Units)

Table 32. Europe Lipid Microbubble Contrast Agent Sales by Country (2025-2030) & (K Units)

Table 33. Europe Lipid Microbubble Contrast Agent Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Lipid Microbubble Contrast Agent Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Lipid Microbubble Contrast Agent Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Lipid Microbubble Contrast Agent Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Lipid Microbubble Contrast Agent Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Lipid Microbubble Contrast Agent Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Lipid Microbubble Contrast Agent Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Lipid Microbubble Contrast Agent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Lipid Microbubble Contrast Agent Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Lipid Microbubble Contrast Agent Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Lipid Microbubble Contrast Agent Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Lipid Microbubble Contrast Agent Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Lipid Microbubble Contrast Agent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Lipid Microbubble Contrast Agent Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Lipid Microbubble Contrast Agent Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Lipid Microbubble Contrast Agent Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Lipid Microbubble Contrast Agent Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Lipid Microbubble Contrast Agent Sales (K Units) by Type (2019-2024)

Table 51. Global Lipid Microbubble Contrast Agent Sales (K Units) by Type (2025-2030)

Table 52. Global Lipid Microbubble Contrast Agent Sales Market Share by Type (2019-2024)

Table 53. Global Lipid Microbubble Contrast Agent Sales Market Share by Type (2025-2030)

Table 54. Global Lipid Microbubble Contrast Agent Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Lipid Microbubble Contrast Agent Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Lipid Microbubble Contrast Agent Revenue Market Share by Type (2019-2024)

Table 57. Global Lipid Microbubble Contrast Agent Revenue Market Share by Type (2025-2030)

Table 58. Global Lipid Microbubble Contrast Agent Price (US$/Unit) by Type (2019-2024)

Table 59. Global Lipid Microbubble Contrast Agent Price (US$/Unit) by Type (2025-2030)

Table 60. Global Lipid Microbubble Contrast Agent Sales (K Units) by Application (2019-2024)

Table 61. Global Lipid Microbubble Contrast Agent Sales (K Units) by Application (2025-2030)

Table 62. Global Lipid Microbubble Contrast Agent Sales Market Share by Application (2019-2024)

Table 63. Global Lipid Microbubble Contrast Agent Sales Market Share by Application (2025-2030)

Table 64. Global Lipid Microbubble Contrast Agent Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Lipid Microbubble Contrast Agent Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Lipid Microbubble Contrast Agent Revenue Market Share by Application (2019-2024)

Table 67. Global Lipid Microbubble Contrast Agent Revenue Market Share by Application (2025-2030)

Table 68. Global Lipid Microbubble Contrast Agent Price (US$/Unit) by Application (2019-2024)

Table 69. Global Lipid Microbubble Contrast Agent Price (US$/Unit) by Application (2025-2030)

Table 70. Lantheus Medical Imaging Corporation Information

Table 71. Lantheus Medical Imaging Description and Business Overview

Table 72. Lantheus Medical Imaging Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Lantheus Medical Imaging Lipid Microbubble Contrast Agent Product

Table 74. Lantheus Medical Imaging Recent Developments/Updates

Table 75. Bracco SpA Corporation Information

Table 76. Bracco SpA Description and Business Overview

Table 77. Bracco SpA Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Bracco SpA Lipid Microbubble Contrast Agent Product

Table 79. Bracco SpA Recent Developments/Updates

Table 80. GE Healthcare Corporation Information

Table 81. GE Healthcare Description and Business Overview

Table 82. GE Healthcare Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. GE Healthcare Lipid Microbubble Contrast Agent Product

Table 84. GE Healthcare Recent Developments/Updates

Table 85. Daiichi Sankyo Company Corporation Information

Table 86. Daiichi Sankyo Company Description and Business Overview

Table 87. Daiichi Sankyo Company Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Daiichi Sankyo Company Lipid Microbubble Contrast Agent Product

Table 89. Daiichi Sankyo Company Recent Developments/Updates

Table 90. Bayer Corporation Information

Table 91. Bayer Description and Business Overview

Table 92. Bayer Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Bayer Lipid Microbubble Contrast Agent Product

Table 94. Bayer Recent Developments/Updates

Table 95. Guerbet Group Corporation Information

Table 96. Guerbet Group Description and Business Overview

Table 97. Guerbet Group Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Guerbet Group Lipid Microbubble Contrast Agent Product

Table 99. Guerbet Group Recent Developments/Updates

Table 100. Hengrui Medicine Corporation Information

Table 101. Hengrui Medicine Description and Business Overview

Table 102. Hengrui Medicine Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Hengrui Medicine Lipid Microbubble Contrast Agent Product

Table 104. Hengrui Medicine Recent Developments/Updates

Table 105. BeiLu Pharmaceutical Corporation Information

Table 106. BeiLu Pharmaceutical Description and Business Overview

Table 107. BeiLu Pharmaceutical Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. BeiLu Pharmaceutical Lipid Microbubble Contrast Agent Product

Table 109. BeiLu Pharmaceutical Recent Developments/Updates

Table 110. Qihui Biology Corporation Information

Table 111. Qihui Biology Description and Business Overview

Table 112. Qihui Biology Lipid Microbubble Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Qihui Biology Lipid Microbubble Contrast Agent Product

Table 114. Qihui Biology Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Lipid Microbubble Contrast Agent Distributors List

Table 118. Lipid Microbubble Contrast Agent Customers List

Table 119. Lipid Microbubble Contrast Agent Market Trends

Table 120. Lipid Microbubble Contrast Agent Market Drivers

Table 121. Lipid Microbubble Contrast Agent Market Challenges

Table 122. Lipid Microbubble Contrast Agent Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Lipid Microbubble Contrast Agent

Figure 2. Global Lipid Microbubble Contrast Agent Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Lipid Microbubble Contrast Agent Market Share by Type in 2023 & 2030

Figure 4. Micron Product Picture

Figure 5. Nanoscale Product Picture

Figure 6. Global Lipid Microbubble Contrast Agent Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Lipid Microbubble Contrast Agent Market Share by Application in 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Other

Figure 11. Global Lipid Microbubble Contrast Agent Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Lipid Microbubble Contrast Agent Market Size (2019-2030) & (US$ Million)

Figure 13. Global Lipid Microbubble Contrast Agent Sales (2019-2030) & (K Units)

Figure 14. Global Lipid Microbubble Contrast Agent Average Price (US$/Unit) & (2019-2030)

Figure 15. Lipid Microbubble Contrast Agent Report Years Considered

Figure 16. Lipid Microbubble Contrast Agent Sales Share by Manufacturers in 2023

Figure 17. Global Lipid Microbubble Contrast Agent Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Lipid Microbubble Contrast Agent Players: Market Share by Revenue in 2023

Figure 19. Lipid Microbubble Contrast Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Lipid Microbubble Contrast Agent Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Lipid Microbubble Contrast Agent Sales Market Share by Country (2019-2030)

Figure 22. North America Lipid Microbubble Contrast Agent Revenue Market Share by Country (2019-2030)

Figure 23. United States Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Lipid Microbubble Contrast Agent Sales Market Share by Country (2019-2030)

Figure 26. Europe Lipid Microbubble Contrast Agent Revenue Market Share by Country (2019-2030)

Figure 27. Germany Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Lipid Microbubble Contrast Agent Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Lipid Microbubble Contrast Agent Revenue Market Share by Region (2019-2030)

Figure 34. China Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Lipid Microbubble Contrast Agent Sales Market Share by Country (2019-2030)

Figure 42. Latin America Lipid Microbubble Contrast Agent Revenue Market Share by Country (2019-2030)

Figure 43. Mexico Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Lipid Microbubble Contrast Agent Sales Market Share by Country (2019-2030)

Figure 47. Middle East & Africa Lipid Microbubble Contrast Agent Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Lipid Microbubble Contrast Agent Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Lipid Microbubble Contrast Agent by Type (2019-2030)

Figure 52. Global Revenue Market Share of Lipid Microbubble Contrast Agent by Type (2019-2030)

Figure 53. Global Lipid Microbubble Contrast Agent Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Lipid Microbubble Contrast Agent by Application (2019-2030)

Figure 55. Global Revenue Market Share of Lipid Microbubble Contrast Agent by Application (2019-2030)

Figure 56. Global Lipid Microbubble Contrast Agent Price (US$/Unit) by Application (2019-2030)

Figure 57. Lipid Microbubble Contrast Agent Value Chain

Figure 58. Lipid Microbubble Contrast Agent Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Distributors Profiles

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Probe Cover Kit with Sterile Gel Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36A15620

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Digital Dental 3D Intraoral Scanner Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-16A15913

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Bench-Top Fundus Camera Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-8B15902

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Chromic Gut Sutures Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-12H15739

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions